Rolff et al. [23] showed that plasma suPAR (suPAR(I-III) + (II-III) and uPAR(I)) levels 6 months after surgery in CRC patients were significantly associated with survival in their multivariate analysis (p ≤ 0.01, respectively). Here, PLAUR is linked to colorectal carcinoma.